| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Imugene Limited (AU: IMU)
IMU Technical Analysis
5
| As on 11th Jul 2023 IMU SHARE Price closed @ 0.09 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.22 & Strong Sell for SHORT-TERM with Stoploss of 0.27 we also expect STOCK to react on Following IMPORTANT LEVELS. |
IMUSHARE Price
| Open | 0.09 | Change | Price | % |
| High | 0.09 | 1 Day | 0.00 | 0.00 |
| Low | 0.09 | 1 Week | 0.00 | 0.00 |
| Close | 0.09 | 1 Month | -0.02 | -18.18 |
| Volume | 11016058 | 1 Year | -0.19 | -67.86 |
| 52 Week High 0.34 | 52 Week Low 0.08 | ||||
AU Australia Most Active Stocks
| MOB | 0.02 | 100.00% |
| SI6 | 0.01 | % |
| GMN | 0.01 | 0.00% |
| LPD | 0.01 | 0.00% |
| LDX | 0.06 | -14.29% |
| S32 | 3.69 | 3.65% |
| WWI | 0.02 | 100.00% |
| HWK | 0.09 | % |
| SYA | 0.19 | 5.56% |
| G88 | 0.05 | -16.67% |
AU Australia Top Gainers Stocks
AU Australia Top Losers Stocks
| IMU Daily Charts |
IMU Intraday Charts |
Whats New @ Bazaartrend |
IMU Free Analysis |
|
|
IMU Important Levels Intraday
| RESISTANCE | 0.09 |
| RESISTANCE | 0.09 |
| RESISTANCE | 0.09 |
| RESISTANCE | 0.09 |
| RESISTANCE | 0.09 |
| RESISTANCE | 0.09 |
| RESISTANCE | 0.09 |
| RESISTANCE | 0.09 |
IMU Forecast April 2024
| 4th UP Forecast | 0.3 |
| 3rd UP Forecast | 0.23 |
| 2nd UP Forecast | 0.19 |
| 1st UP Forecast | 0.15 |
| 1st DOWN Forecast | 0.03 |
| 2nd DOWN Forecast | -0.01 |
| 3rd DOWN Forecast | -0.05 |
| 4th DOWN Forecast | -0.12 |
IMU Weekly Forecast
| 4th UP Forecast | 0.19 |
| 3rd UP Forecast | 0.16 |
| 2nd UP Forecast | 0.14 |
| 1st UP Forecast | 0.12 |
| 1st DOWN Forecast | 0.06 |
| 2nd DOWN Forecast | 0.04 |
| 3rd DOWN Forecast | 0.02 |
| 4th DOWN Forecast | -0.01 |
IMU Forecast2024
| 4th UP Forecast | 0.59 |
| 3rd UP Forecast | 0.43 |
| 2nd UP Forecast | 0.33 |
| 1st UP Forecast | 0.23 |
| 1st DOWN Forecast | -0.05 |
| 2nd DOWN Forecast | -0.15 |
| 3rd DOWN Forecast | -0.25 |
| 4th DOWN Forecast | -0.41 |
Imugene Limited ( AU Australia Symbol : IMU )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
IMU Business Profile
Imugene Limited, a clinical stage immuno-oncology company, develops a range of immunotherapies to activate the immune system of cancer patients to treat and eradicate tumors in Australia. Its lead product is HER-Vaxx, a HER2-positive cancer vaccine that stimulates a polyclonal antibody response against HER2/neu receptors in gastric and breast cancer. The company's HER-Vaxx is in Phase 1b/2 study for gastric cancer. It also engages in developing PD1-Vaxx, a cancer vaccine that aims to induce the body to produce polyclonal antibodies that block PD-1 signalling; B-Vaxx, a cancer vaccine to treat tumors that over-express the HER2/neu receptor; and CF33, a combination of genomic sequences from various vaccinia virus strains to generate potent virus. The company has a research collaboration with Celularity Inc. to develop the combination of Imugene's CD19 oncolytic virus technology and Celularity's CD19 targeting allogeneic chimeric antigen receptor T-cell therapy, CyCART-19 for the treatment of solid tumors. Imugene Limited was incorporated in 1986 and is based in Sydney, Australia. Address: 37 Bligh Street, Sydney, NSW, Australia, 2000
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service